Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Helyezés a részvények között #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Részvényárfolyam
$62.83
Piaci kapitalizáció
$93.23B
Változás (1 nap)
-9.17%
Változás (1 év)
-31.36%
Ország
US
Kereskedés Boston Scientific Corporation (BSX)

Kategória

Bevétel a(z) Boston Scientific Corporation (BSX) részvényhez
Bevétel ekkor: Dec 2025 TTM: $20.08B
Boston Scientific Corporation legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $20.08B. 2024 évben a vállalat $16.75B árbevételt ért el, amely növekedés a 2023 évben elért $14.24B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Boston Scientific Corporation bevételtörténete 2000 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $20.08B 0.00%
2025 $20.07B 19.87%
2024 $16.75B 17.61%
2023 $14.24B 12.29%
2022 $12.68B 6.68%
2021 $11.89B 19.92%
2020 $9.91B -7.66%
2019 $10.74B 9.28%
2018 $9.82B 8.57%
2017 $9.05B 7.89%
2016 $8.39B 12.16%
2015 $7.48B 1.31%
2014 $7.38B 3.32%
2013 $7.14B -1.46%
2012 $7.25B -4.89%
2011 $7.62B -2.36%
2010 $7.81B -4.67%
2009 $8.19B 1.71%
2008 $8.05B -3.67%
2007 $8.36B 6.85%
2006 $7.82B 24.48%
2005 $6.28B 11.72%
2004 $5.62B 61.80%
2003 $3.48B 19.08%
2002 $2.92B 9.20%
2001 $2.67B 0.34%
2000 $2.66B 0.00%
Hasonló cégek vagy versenytársak bevétele
Vállalat Bevétel Bevételkülönbség Ország
$44.33B 120.81%
US
$25.12B 25.11%
US
$35.49B 76.80%
IE
$35.48B 76.76%
IE
$25.70B 28.01%
DE